# Astec LifeSciences Limited (ASTEC)

> ASTEC closed at ₹545.55 on 30 Oct 2026, market cap ₹1,216 cr, latest results for the quarter ended 30 Sept 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Astec LifeSciences Limited (NSE: ASTEC) closed at ₹545.55 on 30 Oct 2026, -25.2% over one year, against a 52-week range of ₹513.40 – ₹941.75.

In the quarter ended 30 Sept 2026 (consolidated, filed 26 Oct 2026) it reported revenue of ₹72 cr and a net loss of ₹37 cr, a -51.9% net margin; revenue fell 2.3% year on year.

No trailing P/E is published: trailing twelve-month earnings are negative (-80 cr), so a P/E has no meaning — a loss-making business is not 'cheap' at a negative multiple. Judge it on revenue growth, cash burn and funding instead.

From the balance sheet dated 30 Sept 2026: return on equity -44.7%, ROCE -33.1%, debt-to-equity 0.99, Piotroski F-score 4 of 9.

Against 43 Chemicals peers on NSE: Net margin higher than 0% of 43 sector peers; PBT margin higher than 0% of 43 sector peers; ROE higher than 0% of 41 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹545.55 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -25.1% / -24.3% / -25.2% |
| 52-week low – high | ₹513.40 – ₹941.75 |
| Market capitalisation | ₹1,216 cr |
| Price / book | 3.63 |
| TTM EPS | ₹-35.71 |
| TTM net profit | ₹-80 cr |
| Quarter revenue | ₹72 cr |
| Quarter net loss | ₹37 cr |
| Net margin | -51.9% |
| Revenue growth (YoY) | -2.3% |
| Profit growth (YoY) | -53.3% |
| Return on equity | -44.7% |
| ROCE | -33.1% |
| Debt / equity | 0.99 |
| Current ratio | 0.74 |
| Free cash flow | ₹120 cr |
| Piotroski F-score | 4 / 9 |
| Average daily turnover (50 days) | ₹2.5 cr |

## Questions

### What were Astec LifeSciences Limited's latest quarterly results?

For the quarter ended 30 Sept 2026, Astec LifeSciences Limited reported revenue of ₹72 cr and a net loss of ₹37 cr (consolidated), filed with the exchange on 26 Oct 2026.

### What is Astec LifeSciences Limited's ROE?

Return on equity is -44.7% based on the balance sheet dated 30 Sept 2026.

### Does Astec LifeSciences Limited have debt?

Debt-to-equity is 0.99 on the balance sheet dated 30 Sept 2026.

### What is ASTEC's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, ASTEC traded between ₹513.40 and ₹941.75.

Sector: [Chemicals](https://trinetra.trade/sectors/chemicals) · Page: https://trinetra.trade/fundamentals/ASTEC

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._